Showing results (11-20 of 126) with videos related to
Sort By:
Pageof 13
Journal of Oncology Practice|August 11, 2017
Can Minimal Residual Disease Determination in Acute Myeloid Leukemia Be Used in Clinical Practice?Marlise R Luskin, Richard M StoneHaematologica|March 23, 2023
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasmMarlise R Luskin, Andrew A LaneAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 3, 2022
Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age SpectrumEmily Curran, Lori Muffly, Marlise R LuskinBlood Advances|June 30, 2023
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemiaShai Shimony, Daniel J DeAngelo, Marlise R LuskinFuture Oncology (London, England)|September 8, 2025
How I treat Ph+ acute lymphoblastic leukemiaMelanie Castro-Mollo, Daniel J DeAngelo, Marlise R LuskinActa Haematologica|June 10, 2025
Treatment of Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaLourdes M Mendez, Daniel J DeAngelo, Marlise R LuskinCurrent Hematologic Malignancy Reports|July 12, 2015
A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic MalignanciesMarlise R Luskin, Rahul Banerjee, Sarah Del Percio, et al.American Journal of Hematology|February 4, 2025
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1Evan C Chen, Shai Shimony, Marlise R Luskin, et al.Blood Cancer Discovery|March 30, 2026
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALLCaner Saygin, Matthew T Witkowski, Sinan Cetin, et al.Nature Reviews. Cancer|January 30, 2018
Targeting minimal residual disease: a path to cure?Marlise R Luskin, Mark A Murakami, Scott R Manalis, et al.Pageof 13